These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8713791)
1. Proteins of the fibrinolytic system in human thrombi. Robbie LA; Bennett B; Croll AM; Brown PA; Booth NA Thromb Haemost; 1996 Jan; 75(1):127-33. PubMed ID: 8713791 [TBL] [Abstract][Full Text] [Related]
2. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis. Robbie LA; Booth NA; Croll AM; Bennett B Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139 [TBL] [Abstract][Full Text] [Related]
3. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
4. Demonstration of a functionally active tPA-like plasminogen activator in human platelets. Wang DL; Pan YT; Wang JJ; Cheng CH; Liu CY Thromb Haemost; 1994 Apr; 71(4):493-8. PubMed ID: 8052969 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
6. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma]. Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741 [TBL] [Abstract][Full Text] [Related]
7. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors. Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230 [TBL] [Abstract][Full Text] [Related]
8. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury. Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
10. Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and RAI-1 content and distribution. Robbie LA; Young SP; Bennett B; Booth NA Thromb Haemost; 1997 Mar; 77(3):510-5. PubMed ID: 9066003 [TBL] [Abstract][Full Text] [Related]
12. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445 [TBL] [Abstract][Full Text] [Related]
13. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1. Dewerchin M; Collen D; Lijnen HR Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016 [TBL] [Abstract][Full Text] [Related]
14. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021 [TBL] [Abstract][Full Text] [Related]
15. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448 [TBL] [Abstract][Full Text] [Related]
16. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin. Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718 [TBL] [Abstract][Full Text] [Related]
17. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655 [TBL] [Abstract][Full Text] [Related]
18. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms]. Banfi C; Mussoni L; Tremoli E Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793 [TBL] [Abstract][Full Text] [Related]
19. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. Angles-Cano E; Gris JC; Loyau S; Schved JF J Lab Clin Med; 1993 May; 121(5):646-53. PubMed ID: 8478593 [TBL] [Abstract][Full Text] [Related]
20. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood. van Giezen JJ; Nerme V; Abrahamsson T Blood Coagul Fibrinolysis; 1998 Jan; 9(1):11-8. PubMed ID: 9607114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]